More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy

There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years. Further, recent studies suggest that mesenchymal stem cells mesenchymal stem cells can be effectively used to improve patients' resistance to the SARS-CoV-2 virus induced pneumonia leading to speedy recovery.
 
To order this 500+ page report, which features 185+ figures and 220+ tables, please visit this link
 
The USD 8.5 billion (by 2030) financial opportunity within the stem cell therapies market has been analyzed across the following segments:
Source of stem cell
Allogeneic
Autologous
Origin of stem cell
  • Adult
  • Embryonic
  • Type of stem cell
  • Hematopoietic
  • Mesenchymal
  • Progenitor
  • Others

Lineage of stem cell
Adipose Tissue
Bone Marrow
Cord Blood
Others
Route of Administration
Intraarticular
Intracoronary
Intramuscular
Intramyocardial
Intrathecal
Intravenous
Surgical Implantations
Others
Therapeutic Area
Autoimmune / Inflammatory Disorder
Cardiovascular Disorders
Metabolic Disorder
Musculoskeletal Disorders
Oncological Disorders
Neurological Disorders
Ophthalmic Disorders
Others
End Users
Ambulatory Surgery Centers
Hospitals
Specialty Clinics
Key Geographies
North America
Europe
Asia-Pacific and Rest of the World


The Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent)), report features the following companies, which we identified to be key players in this domain: 
  • Anterogen
  • Athersys
  • CHABiotech
  • Cytopeutics
  • Hope Biosciences
  • Japan Regenerative Medicine
  • Lineage Cell Therapeutics
  • Orchard Therapeutics
  • Osiris Therapeutics
  • Pluristem Therapeutics
  • Promithera Biosciences
  • Regenexx
  • Stempeutics Research
  • SCM Life Sciences

TICEBA

 
Table of Contents
 
1. Preface

2. Executive Summary

3. Introduction


4. Market Landscape


5. Company Profiles


6. Key Therapeutic Areas


7. Assessment of Relative Competition and Growth Opportunities


8. Academic Grants Analysis


9. Clinical Trail Analysis 


10. Stem Cell Manufacturing Market Landscape and KPIs for Evaluating Contract
Services Partners


11. Stem Cell Therapy Developers and CMOs: Opportunity Assessment


12. Key Commercialization Strategies
 
13. Market Forecast


14. Conclusion 


15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
 
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
 [email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
390 Posts

Made with by Mamby